Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
Debates & Insight Sponsored Available on demand: Social medical: The social media buzz a... Join us for a one-hour live webinar discussing the social media buzz around this year’s ASCO Annual Meeting.
Debates & Insight Sponsored From promise to practice: immuno-oncology in action – the ne... Immuno-oncology therapies that harness the body's own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment.
Debates & Insight Sponsored Round table transcript: Oncology shaping the future of perso... Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.